期刊文献+

非甾体类抗炎药致上消化道出血366例临床分析

Clinical analysis of 366 cases of upper gastrointestinal bleeding caused by non-steroidal anti-inflammatory drugs
下载PDF
导出
摘要 目的探讨非甾体类抗炎药(NSAIDs)诱发上消化道出血(PU)的临床流行病学特点。方法调查中山大学孙逸仙纪念医院2002年1月至2009年1月间因上消化道出血收住院治疗366例患者,根据入院前1周内有无服用NSAIDs,将患者分为服药组(103例)及未服药组(263例),对两组患者的临床资料进行分析比较。结果服药组患者的年龄较未服药组更高,血红蛋白在服药组下降更明显(P<0.01);胃溃疡和复合溃疡、多发溃疡在服药组更多见(P<0.01),服药组幽门螺杆菌(Hp)的感染率与未服药组的感染率有显著差异,分别为65.05%和26.24%,(P<0.05)。结论应加强对NSAIDs相关性上消化道出血临床特点的认识,尽量减少NSAIDs的不良反应。 Objective To study the clinico-epidemiological features of the upper gastrointestinal bleeding caused by non-steroidal anti-inflammatory drugs.Methods 366 cases of upper gastrointestinal bleeding from Jan.2002 to Jan.2009 in The Sun Yat-sen Hospital of Sun Yat-sen University were investigated.Patients were divided into treated group(103 cases)and untreated group(263 cases)according to whether they had had NSAIDs in one week before admission.And the clinical data of the two groups of patients were analyzed.Results The treated group was older than the untreated group.Hemoglobin was significantly decreased in the treated group(P〈0.01).There were more gastric ulcer,complex ulcer and multiple ulcers in the treated group.The rate of Helicobacter Pylori(HP)Infection in treated group was obviously different from that in untreated group,which was 65.05%and 26.24%(P〈0.05).Conclusion The clinical characteristics of the upper gastrointestinal bleeding caused by non-steroidal anti-inflammatory drugs should be emphasized and we should reduce the adverse reactions to NSAIDs.
出处 《中国实用医药》 2010年第11期18-19,共2页 China Practical Medicine
关键词 非甾体类抗炎药 上消化道出血 NSAIDs Upper gastrointestinal bleeding
  • 相关文献

参考文献7

  • 1Dubois RW, Melmed GY, Henning JM, et al. Risk of Upper Gastrointestinal Injury and Events in Patients Treated With Cyelooxygenase (COX) -1/COX-2 Nonsteroidal Antiinflammatory Drugs ( NSAIDs ), COX-2 Seleetive NSAIDs, and Gastroproteetive Cotherapy: An Appraisal of the Literature. J Clin Rheumatol,2004,10(4) :178-189.
  • 2Laine L. GI risk and risk factors of NSAIDs. J Cardiovase Pharmacol ,2006,47( Suppl 1 ) :60-66.
  • 3Sakamoto C, Sugano K, Ota S,et al. Case-control study on the association of upper gastrointestinal bleeding and nonsteroidal anti-inflammatory drugs in Japan. Eur J Clin Pharmacol, 2006,62 ( 9 ) : 765 -772.
  • 4Scheiman JM. Unmet needs in non-steroidal anti-inflammatory druginduced upper gastrointestinal diseases. Drugs ,2006,66( Suppl 1 ) : 15-21 ; discassion 29-33.
  • 5Insua J, Mavros P, Hunsche E, et al. Exposure to nonsteroidal antiinflammatory drugs among older adult patients hospitalized for peptic ulcer disease in Argentina: A case-control study. Am J Geriatr Pharmacother,2006,4(3 ) :251-259.
  • 6Pilotto A, Franceschi M, Vitale DF, et al. Upper gastrointestinal symptoms and therapies in elderly out-patients, users of non-selective NSAIDs or coxibs. Aliment Pharmacol Ther, 2005,22 (2): 147 -155.
  • 7Lanas A, Ferrandez A. NSAID-induced gastrointestinal damage:current clinical management and recommendations for prevention. Chin J Dig Dis,2006,7 (3) : 127-133.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部